Literature DB >> 10650962

Central administration of cocaine-amphetamine-regulated transcript activates hypothalamic neuroendocrine neurons in the rat.

N Vrang1, P J Larsen, P Kristensen, M Tang-Christensen.   

Abstract

We have recently shown that intracerebroventricular (i.c.v.) administration of the hypothalamic neuropeptide cocaine-amphetamine-regulated transcript (CART) inhibits food intake and induces the expression of c-fos in several nuclei involved in the regulation of food intake. A high number of CART-induced c-Fos-positive nuclei in the paraventricular nucleus of the hypothalamus prompted us to examine the effect of i.c.v. recombinant CART-(42-89) on activation of CRH-, oxytocin-, and vasopressin-synthesizing neuroendocrine cells in the paraventricular nucleus (PVN). In addition, plasma levels of glucose were examined after central administration of CART-(42-89). Seventy-six male Wistar rats were fitted with i.c.v. cannulas and singly housed under 12-h light, 12-h dark conditions. One week postsurgery the animals were injected i.c.v. in the morning with 0.5 microg recombinant CART-(42-89) or saline. Trunk blood was collected by decapitation at 0 (baseline), 10, 20, 40, 60, 120, or 240 min. CART caused a strong increase in circulating corticosterone that was significantly different from saline at 20, 40, 60, and 120 min postinjection (P<0.05). Furthermore, CART caused a transient rise in plasma oxytocin levels (P<0.05 at 10 and 20 min postinjection), whereas plasma vasopressin levels were unaffected by i.c.v. CART. Animals injected i.c.v. with CART showed a rise in blood glucose levels 10 min postinjection (P<0.05). To examine whether the stimulatory effect of i.c.v. CART on corticosterone and oxytocin secretion is caused by activation of paraventricular nucleus/supraoptic nucleus (PVN/SON) neuroendocrine neurons, we used c-Fos as a marker of neuronal activity. Animals injected with CART showed a strong increase in c-Fos-immunoreactive nuclei in the PVN. Double immunohistochemistry revealed that a high (89+/-0.4%) number of CRH-immunoreactive neurons in the PVN contained c-Fos after CART i.c.v.. c-Fos expression was also observed in oxytocinergic cells (in both magnocellular and parvicellular PVN neurons as well as in the supraoptic nuclei) 120 min after CART administration, whereas none of the vasopressinergic neurons contained c-Fos. Triple immunofluorescence microscopy revealed that CART-immunoreactive fibers closely apposed c-Fos-positive CRH neurons, suggestive of a direct action of CART on PVN CRH neurons. In summary, i.c.v. CART activates central CRH neurons as well as both magnocellular (presumably neurohypophysial) and parvicellular (presumably descending) oxytocinergic neurons of the PVN. The effect of CART on CRH neurons most likely leads to corticosterone secretion from the adrenal gland, which may contribute to the inhibitory effects of CART on feeding behavior.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10650962     DOI: 10.1210/endo.141.2.7295

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  30 in total

Review 1.  Oxytocin as feeding inhibitor: maintaining homeostasis in consummatory behavior.

Authors:  Pawel K Olszewski; Anica Klockars; Helgi B Schiöth; Allen S Levine
Journal:  Pharmacol Biochem Behav       Date:  2010-06-02       Impact factor: 3.533

Review 2.  Interacting Neural Processes of Feeding, Hyperactivity, Stress, Reward, and the Utility of the Activity-Based Anorexia Model of Anorexia Nervosa.

Authors:  Rachel A Ross; Yael Mandelblat-Cerf; Anne M J Verstegen
Journal:  Harv Rev Psychiatry       Date:  2016 Nov/Dec       Impact factor: 3.732

Review 3.  Cocaine- and amphetamine-regulated transcript peptides play a role in drug abuse and are potential therapeutic targets.

Authors:  Michael J Kuhar; Jason N Jaworski; George W Hubert; Kelly B Philpot; Geraldina Dominguez
Journal:  AAPS J       Date:  2005-09-02       Impact factor: 4.009

Review 4.  Appetite Regulation: Hormones, Peptides, and Neurotransmitters and Their Role in Obesity.

Authors:  Gary D Miller
Journal:  Am J Lifestyle Med       Date:  2017-06-23

5.  Cocaine- and amphetamine-regulated transcript accelerates termination of follicle-stimulating hormone-induced extracellularly regulated kinase 1/2 and Akt activation by regulating the expression and degradation of specific mitogen-activated protein kinase phosphatases in bovine granulosa cells.

Authors:  Aritro Sen; Lihua Lv; Nora Bello; James J Ireland; George W Smith
Journal:  Mol Endocrinol       Date:  2008-09-25

6.  Leptin-Induced CART (Cocaine- and Amphetamine-Regulated Transcript) Is a Novel Intraovarian Mediator of Obesity-Related Infertility in Females.

Authors:  Xiaoting Ma; Emily Hayes; Hen Prizant; Rajesh K Srivastava; Stephen R Hammes; Aritro Sen
Journal:  Endocrinology       Date:  2016-01-05       Impact factor: 4.736

7.  Intraperitoneal Administration of CART 55-102 Inhibits Psychostimulant-Induced Locomotion.

Authors:  Martin O Job; Michael J Kuhar
Journal:  J Drug Alcohol Res       Date:  2012-01-01

8.  Region- and sex-specific changes in CART mRNA in rat hypothalamic nuclei induced by forced swim stress.

Authors:  Burcu Balkan; Oguz Gozen; Ersin O Koylu; Aysegul Keser; Michael J Kuhar; Sakire Pogun
Journal:  Brain Res       Date:  2012-08-31       Impact factor: 3.252

9.  Regulation of cocaine- and amphetamine-regulated transcript-synthesising neurons of the hypothalamic paraventricular nucleus by endotoxin; implications for lipopolysaccharide-induced regulation of energy homeostasis.

Authors:  T Füzesi; E Sánchez; G Wittmann; P S Singru; C Fekete; R M Lechan
Journal:  J Neuroendocrinol       Date:  2008-07-08       Impact factor: 3.627

10.  Effect of desipramine and citalopram treatment on forced swimming test-induced changes in cocaine- and amphetamine-regulated transcript (CART) immunoreactivity in mice.

Authors:  Sung Chung; Hee Jeong Kim; Hyun Ju Kim; Sun Hye Choi; Jin Wook Kim; Jeong Min Kim; Kyung Ho Shin
Journal:  Neurochem Res       Date:  2014-04-20       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.